Filing Flows › Nutra Pharma (NPHC) › Q1 2026 › vs Q1 2025
Nutra Pharma (NPHC) Q1 2026 vs Q1 2025 (year over year)
Nutra Pharma's revenue fell $47K (-63%) from $74K in Q1 2025 to $27K in Q1 2026.
Nutra Pharma, Q1 2026: revenue $27K (-63% year over year), net loss $460K, operating cash flow −$328K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $27K | $74K | −$47K | -63% |
| Net loss | $460K | $1.4M | −$945K | -67% |
| Costs & expenses | $487K | $1.5M | −$992K | -67% |
| Operating costs | $406K | $424K | −$17K | -4% |
| Interest & other, net | $80K | $1.1M | −$975K | -92% |
| Cost of revenue | $8K | $15K | −$7K | -44% |
| Operating expenses | $398K | $409K | −$11K | -3% |
| Operating cash sources | $460K | $1.4M | −$945K | -67% |
| Depreciation | $3K | $2K | $356 | +17% |
| Share-based compensation | $11K | $0 | $11K | — |
| Working capital & other | $118K | $998K | −$880K | -88% |
| Cash used in operations | $328K | $405K | −$77K | -19% |
| Net loss absorbed | $460K | $1.4M | −$945K | -67% |
Questions
How much did Nutra Pharma's revenue grow year over year in Q1 2026?
Nutra Pharma's revenue fell $47K (-63%) from $74K in Q1 2025 to $27K in Q1 2026.